THC Farmaceuticals, Inc. Stock

CBDG

US87243T1007

Biotechnology & Medical Research

Market Closed - OTC Markets 11:11:50 2026-05-28 EDT			5-day change	1st Jan Change
0.0180 ^USD	-.--%		-35.48%	-52.63%

23-02-07	THC Farmaceuticals, Inc. announced that it expects to receive $0.124 million in funding	CI
21-06-28	Thc Farmaceuticals, Inc. Announces Final Departure of Mike Gravel, Chairman	CI

Valuation: THC Farmaceuticals, Inc.

Market Cap	6M 5.18M 4.86M 4.43M 8.32M 574M 8.44M 56.95M 22.32M 287M 22.52M 22.03M 956M	P/E 2013 *	-	P/E 2014	-321x
Enterprise Value	6.08M 5.25M 4.92M 4.48M 8.43M 581M 8.54M 57.68M 22.6M 291M 22.81M 22.32M 968M	EV / Sales 2013 *	-	EV / Sales 2014	522x
Free-Float	20.62%	Yield 2013 *	-	Yield 2014	-

* Estimated data More valuation ratios

Chart: THC Farmaceuticals, Inc.

Dynamic Chart

Latest news : THC Farmaceuticals, Inc.

23-02-07	THC Farmaceuticals, Inc. announced that it expects to receive $0.124 million in funding	CI
21-06-28	Thc Farmaceuticals, Inc. Announces Final Departure of Mike Gravel, Chairman	CI
21-06-28	THC Farmaceuticals, Inc. Announces Departure of Its CEO, Mike Gravel	CI
21-05-03	THC Farmaceuticals, Inc. acquired 51% stake in GK Manufacturing and Packaging, Inc. from Cannabis Sativa, Inc. for $0.9 million.	CI
21-05-03	THC Farmaceuticals, Inc. and Rubin's Dental Anxiety Pills entered into a binding agreement to acquire an unknown majority stake in GK Manufacturing and Packaging, Inc. from Cannabis Sativa, Inc..	CI
20-12-07	CBDual Biotechnology Corp., Subsidiary of THC Farmaceuticals, Inc. Completes the Research and Development of New CBD Based Dental Anxiety Formulation	CI
15-09-03	Jon McGee Resigns as an Officer and Director of THC Farmaceuticals	CI
15-06-29	THC Farmaceuticals, Inc. Appoints Ed Rosenthal as President	CI
15-05-20	THC Farmaceuticals, Inc. Appoints Mike Gravel as Chief Executive Officer and Chairman of the Board	CI
15-04-13	THC Farmaceuticals, Inc. Announces Resignation of Patrick Bilton as Director	CI
15-04-08	City Media, Inc. will Change its Name to THC Farmaceuticals, Inc	CI
15-01-20	City Media, Inc. will Change its Ticker to CBDG from CTYM	CI
14-12-23	City Media, Inc. Announces Board Changes	CI

More news

Press Releases: THC Farmaceuticals, Inc.

21-06-28	Legendary Hero Senator Mike Gravel Ended Final Career As Chairman and CEO of THC Farmaceuticals, Inc When He Passed Away This Weekend	GL
21-05-04	THC Farmaceuticals, Inc. Acquires Controlling Interest in G.K. Manufacturing from Cannabis Sativa, Inc.	GL
20-12-07	DR. RUBIN'S ANXIETY PILL MADE OF CANNABIS TO HIT THE MARKET NEXT WEEK	GL

More press releases

Managers and Directors: THC Farmaceuticals, Inc.

Manager	Title	Age	Since
Mark Grossman CEO	Chief Executive Officer	-	-
Gary Henrie LAW	General Counsel	72	-

Director	Title	Age	Since
David Tobias BRD	Director/Board Member	75	-
Mark Grossman BRD	Director/Board Member	-	-

More insiders

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
THC FARMACEUTICALS, INC.	-.--%	-35.48%	-80.43%	+4,400.00%	506K
LONZA GROUP AG	+0.68%	-2.28%	+2.16%	+19.70%	48.42B
REVOLUTION MEDICINES, INC.	+4.07%	+2.43%	+483.70%	+623.80%	43.66B
BEONE MEDICINES AG	+4.33%	+0.98%	+12.80%	+88.53%	39.51B
IQVIA HOLDINGS INC.	+1.94%	-0.31%	+26.24%	+12.62%	38.95B
CELLTRION, INC.	-0.50%	0.00%	+20.60%	+60.49%	32.61B
ASCENDIS PHARMA A/S	-0.44%	-3.22%	-	-	16.32B
MEDPACE HOLDINGS, INC.	+3.22%	-0.88%	+30.42%	+135.47%	16.15B
EUROFINS SCIENTIFIC SE	-0.62%	-0.06%	+3.46%	+27.74%	14.16B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+2.35%	+3.48%	+82.95%	+43.41%	13.37B
Average	+1.50%	+0.02%	+64.66%	+601.31%	26.31B
Weighted average by Cap.	+1.93%	+0.04%	+101.58%	+151.18%

See all sector performances

THC Farmaceuticals, Inc. is a clinical-stage biotechnology company. The Company specializes in the discovery, development, and commercialization of novel cannabinoid-based products in dental, ophthalmology and other medical disciplines. It offers the combination of its proprietary developments with its clinicians and scientists to unlock the therapeutic properties of cannabis and its bioactive compounds. The Company owns clinical research center and cannabidiol (CBD) manufacturing facility in California. Its business plan includes conducting cannabinoids research and development in collaboration with cannabis research centers worldwide with the goal of developing novel and advanced therapeutic methods for the treatment of common medical conditions with cannabis-based therapies and to conduct pre-clinical investigations and randomized, placebo-controlled trials of CBD-based compounds and develop condition-specific medications. It offers a network of micro vending kiosk systems.

Employees

Sector

Biotechnology & Medical Research

More about the company

Stock Market
Stocks
CBDG Stock

As early as today, start finding the best investment opportunities!

1 week	-35.48%
Current month	+150.00%
1 month	-25.00%
6 months	-10.00%
Current year	-52.63%

1 month	0.01	0.03
Current year	0	0.05
1 year	0	0.09
3 years	0	0.1
5 years	0	0.25
10 years	0	8

	2013	2014
Net sales	21.64K 18.68K 17.53K 15.96K 30.02K 2.07M 30.43K 205K 80.51K 1.04M 81.25K 79.49K 3.45M	19.03K 16.43K 15.42K 14.04K 26.4K 1.82M 26.77K 181K 70.82K 912K 71.46K 69.91K 3.03M
Net income	-23.84K -20.58K -19.31K -17.58K -33.06K -2.28M -33.52K -226K -88.69K -1.14M -89.49K -87.56K -3.8M	-30.7K -26.5K -24.86K -22.64K -42.58K -2.94M -43.17K -291K -114K -1.47M -115K -113K -4.89M
Net Debt	58.16K 50.21K 47.11K 42.91K 80.68K 5.56M 81.8K 552K 216K 2.79M 218K 214K 9.27M	77.06K 66.53K 62.41K 56.85K 107K 7.37M 108K 732K 287K 3.69M 289K 283K 12.28M

THC Farmaceuticals, Inc. Stock

Stocks

CBDG

US87243T1007

Biotechnology & Medical Research

Valuation: THC Farmaceuticals, Inc.

Chart: THC Farmaceuticals, Inc.

Latest news : THC Farmaceuticals, Inc.

Press Releases: THC Farmaceuticals, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: THC Farmaceuticals, Inc.

Other Biotechnology & Medical Research

Financials

Company Profile